Wellgistics Health, Inc.
جودة البيانات: 100%
WGRX
Nasdaq
Wholesale Trade
Nondurable Goods Wholesale
KWD 0.11
▼
KWD 0.02
(-15.87%)
القيمة السوقية: 12.74 M
السعر
KWD 0.11
القيمة السوقية
12.74 M
نطاق اليوم
KWD 0.10 — KWD 0.12
نطاق 52 أسبوعًا
KWD 0.10 — KWD 7.04
حجم التداول
9,357,272
فتح KWD 0.12
متوسط 50 يوم / 200 يوم
KWD 0.23
53.12% below
متوسط 50 يوم / 200 يوم
KWD 0.65
83.77% below
Quick Summary
النقاط الرئيسية
Debt/Equity of 3.66 — high leverage
Negative free cash flow of -5.79 M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)-22.32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-2089.68%
أقل من متوسط القطاع (-4.23%)
ROIC-369.67%
Net Margin-201.72%
Op. Margin-187.31%
الأمان
Debt / Equity
3.66
أعلى من متوسط القطاع (0.33)
Current Ratio0.39
Interest Coverage-16.44
التقييم
PE (TTM)
-0.16
أقل من متوسط القطاع (-0.15)
P/B Ratio1.88
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Wholesale Trade (91 نظير)
مقارنة الأقران
مقابل وسيط قطاع Wholesale Trade (91 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.2 | -0.2 |
| P/B | 1.9 | 1.0 |
| ROE % | -2089.7 | -4.2 |
| Net Margin % | -201.7 | -2.7 |
| Rev Growth 5Y % | — | 3.6 |
| D/E | 3.7 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -22.32% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39.80 M | Net Income (TTM) | -80.28 M |
| ROE | -2089.68% | ROA | -150.05% |
| Gross Margin | 8.03% | Operating Margin | -187.31% |
| Net Margin | -201.72% | Free Cash Flow (TTM) | -5.79 M |
| ROIC | -369.67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3.66 | Current Ratio | 0.39 |
| Interest Coverage | -16.44 | Asset Turnover | 0.74 |
| Working Capital | -19.92 M | Tangible Book Value | -11.69 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.16 | Forward P/E | N/A |
| P/B Ratio | 1.88 | P/S Ratio | 0.32 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -45.44% | ||
| Market Cap | 12.74 M | Enterprise Value | 33.32 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.33 | Revenue / Share | 0.33 |
| FCF / Share | -0.05 | OCF / Share | -0.05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 7.21% |
| SBC-Adj. FCF | -6.87 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenue | 18.13 M | 23.34 M |
| Net Income | -6.86 M | -101.27 M |
| EPS (Diluted) | -0.15 | -1.43 |
| Gross Profit | 1.77 M | -6.43 M |
| Operating Income | -6.15 M | -93.75 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | 1.11 M | 3.21 M |
| Interest Expense | 831,467.0 | 4.58 M |
| Income Tax | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2025 |
|---|---|---|
| Total Assets | 57.33 M | 30.46 M |
| Total Liabilities | 50.60 M | 42.91 M |
| Shareholders' Equity | 6.73 M | -12.45 M |
| Total Debt | 23.38 M | 23.49 M |
| Cash & Equivalents | 1.03 M | 42,571.0 |
| Current Assets | 15.17 M | 2.82 M |
| Current Liabilities | 38.05 M | 29.78 M |
{"event":"ticker_viewed","properties":{"ticker":"WGRX","listing_kind":"stock","pathname":"/stocks/wgrx","exchange":"Nasdaq","country":"US"}}